Is a complete SCYX research report available?

No complete published report is available for SCYNEXIS, Inc. (SCYX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

SCYNEXIS, Inc. (SCYX)

NASDAQ: SCYX · USD

$3.73

-0.04 (-1.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first SCYX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	37M
Revenue (ttm)	20.3M
Net income (ttm)	-24.5M
EPS (ttm)	-$3.90
Shares out	9.9M
Volume	58,887
Beta	1.10
Price target	$33.6	+799.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 20.3M
Net income (ttm): -24.5M
EPS (ttm): -$3.90
Market cap: 37M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All SCYX indicators

Market & fundamental data

Available fields

207

Groups with data

Currency

USD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001178253
Company name	SCYNEXIS, Inc.
Country	United States
Country code	US
Cusip	811292309
Employees	18
Employees Change	-10%
Employees Change Percent	-35.71
Enterprise value	$-20.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	114.9
Industry PE Fwd	13.93
IPO Date	2014-05-02
Isin	US8112923094
Last refreshed	2026-07-31
Market cap	$37M
Market cap category	Nano-Cap
Price	$3.73
Price currency	USD
Rev Per Employee	1,130,222.22x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	SCYX
Website	https://www.scynexis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-66.55%
FCF yield	-16.07%
P/B ratio	0.7x
P/S ratio	1.81x
PS Forward	24.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-129.02%
EBITDA Margin	-129.02%
Gross margin	100%
Gross Profit	$20.3M
Gross Profit Growth	673.54%
Gross Profit Growth3 Y	61.08%
Gross Profit Growth5 Y	11.04%
Net Income	$-24.5M
Net Income Growth Years	1%
Pretax Margin	-120.51%
Profit Margin	-120.51%
Profit Per Employee	$-1.4M
ROA	-20.96
Roa5y	-15.68
ROCE	-39.5
ROE	-53.39
Roe5y	-51.76
ROIC	-136.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-31.4%
Cagr1y	-34.26%
Cagr3y	-45.8%
Cagr5y	-42.32%
EPS Growth Years	1
Revenue Growth	673.54x
Revenue Growth Years	1x
Revenue Growth3 Y	54.34x
Revenue Growth5 Y	11.04x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.28
Assets	$77.6M
Cash	$59.3M
Current Assets	$62.7M
Current Liabilities	$15.9M
Debt	$2.1M
Debt Equity	$0.05
Equity	$41.3M
Liabilities	$36.3M
Long Term Assets	$14.9M
Long Term Liabilities	$20.4M
Net Cash	$57.2M
Net Cash By Market Cap	$155
Net Cash Growth	50.06%
Net Debt Equity	$-1.38
Tangible Book Value	$41.3M
Tangible Book Value Per Share	$5.33
WACC	9.78

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.94
Net Working Capital	$-12M
Quick ratio	3.73
Working Capital	$46.8M
Working Capital Turnover	$0.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.08%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-97.69%
1Y total return	-34.24%
200-day SMA	5.74
3Y total return	-84.09%
50-day SMA	4.46
50-day SMA vs 200-day SMA	50under200
5Y total return	-93.61%
All Time High	1,200
All Time High Change	-99.69%
All Time High Date	2015-01-13
All Time Low	3.53
All Time Low Change	5.67%
All Time Low Date	2026-07-27
ATR	0.36
Beta	1.1
Beta1y	1.6
Beta2y	1.31
Ch YTD	-26.27
High	3.86
High52	10.48
High52 Date	2025-09-12
High52ch	-64.41%
Low	3.55
Low52	3.53
Low52 Date	2026-07-28
Low52ch	5.67%
Ma50ch	-16.31%
Price vs 200-day SMA	-35.05%
RSI	38.51
RSI Monthly	34.96
RSI Weekly	35.56
Sharpe ratio	-0.27x
Sortino ratio	-0.32
Total Return	-3.08%
Tr YTD	-26.27
Tr1m	-3.62%
Tr1w	-5.81%
Tr3m	-50.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$3
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.49
Earnings Revenue Estimate	80,330x
Earnings Revenue Estimate Growth	-94.11x
Operating Income	$-24.4M
Operating margin	-120
Price target	$33.55
Price Target Change	$799
Price Target Change Top	$-19.57

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,689,345%
Float Percent	77.43%
Shares Insiders	1.91%
Shares Institutions	23.01%
Shares Out	9,930,329
Shares Qo Q	0.62%
Shares Yo Y	3.08%
Short Float	4.52%
Short Ratio	3.68
Short Shares	3.5

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-8.5M
Adjusted OCF	-8,532,000
Average Volume	79,296.45x
Bv Per Share	5.33
Ch10y	-97.69
Ch1m	-3.62
Ch1w	-5.81
Ch1y	-34.24
Ch3m	-50.09
Ch3y	-84.09
Ch5y	-93.61
Ch6m	-37.04
Change	-1.06%
Change From Open	-3.37
Close	3.77
Days Gap	2.39
Dollar Volume	219,648.5
Earnings Date	2026-08-11
Earnings Time	amc
EBIT	$-24.4M
EBITDA	$-24.4M
EPS	$-3.9
F Score	2
FCF	$-5.9M
FCF EV Yield	29.07x
FCF Per Share	$-0.6
Financing CF	23,952,000
Fiscal Year End	December
Founded	1,999
Investing CF	11,341,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Date	2026-06-01
Last Split Type	Reverse
Last10k Filing Date	2026-03-04
Ma150	5.87
Ma150ch	-36.41%
Ma20	4.23
Ma20ch	-11.88%
Net CF	29,374,000
Next Earnings Date	2026-08-12
Open	3.86
Optionable	Yes
Position In Range	58.73
Post Close	3.73
Postmarket Change Percent	-0.54
Postmarket Price	$3.71
Ppne	1,673,000
Price Date	2026-07-30
Ptbv Ratio	0.89
Relative Volume	0.74x
Revenue	20,344,000x
SBC By Revenue	12.84x
Share Based Comp	2,613,000
Tr6m	-37.04%
Us State	New Jersey
Volume	58,887
Z Score	-6.84

SCYNEXIS, Inc. (SCYX)

Coverage state: Market snapshot only — no published research

Generate the first SCYX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · SCYX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SCYX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SCYX

Frequently asked questions